Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease

被引:65
作者
Ahlskog, JE [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
关键词
Parkinson's disease; oxidative stress; dopamine; levodopa;
D O I
10.1002/mds.20362
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Oxidative stress is well documented in Parkinson's disease (PD) and has been attributed to dopamine oxidative metabolism. However, evidence of oxidative stress is found in a variety of neurodegenerative disorders, suggesting that more general factors are responsible or that cytodestructive processes secondarily generate oxyradical products. Increasing evidence points away from dopamine metabolism as an important contributor to PD neurodegeneration. Predictions front the dopamine oxidative stress hypothesis of PD reveal multiple inconsistencies. Although the clinical and therapeutic importance of the nigrostriatal dopaminergic system is undeniable, PD neuropathology is much more widespread. (c) 2004 Movement Disorder Society.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 192 条
  • [1] Frequency of bowel movements and the future risk of Parkinson's disease
    Abbott, RD
    Petrovitch, H
    White, LR
    Masaki, KH
    Tanner, CM
    Curb, JD
    Grandinetti, A
    Blanchette, PL
    Popper, JS
    Ross, GW
    [J]. NEUROLOGY, 2001, 57 (03) : 456 - 462
  • [2] AGID Y, 1990, ADV NEUROL, V53, P83
  • [3] Slowing Parkinson's disease progression - Recent dopamine agonist trials
    Ahlskog, JE
    [J]. NEUROLOGY, 2003, 60 (03) : 381 - 389
  • [4] REDUCED D2 DOPAMINE AND MUSCARINIC CHOLINERGIC RECEPTOR DENSITIES IN CAUDATE SPECIMENS FROM FLUCTUATING PARKINSONIAN-PATIENTS
    AHLSKOG, JE
    RICHELSON, E
    NELSON, A
    KELLY, PJ
    OKAZAKI, H
    TYCE, GM
    VANHEERDEN, JA
    STODDARD, SL
    CARMICHAEL, SW
    [J]. ANNALS OF NEUROLOGY, 1991, 30 (02) : 185 - 191
  • [5] Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
    Ahlskog, JE
    Muenter, MD
    [J]. MOVEMENT DISORDERS, 2001, 16 (03) : 448 - 458
  • [6] Alam ZI, 1997, J NEUROCHEM, V69, P1326
  • [7] Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra
    Alam, ZI
    Jenner, A
    Daniel, SE
    Lees, AJ
    Cairns, N
    Marsden, CD
    Jenner, P
    Halliwell, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) : 1196 - 1203
  • [8] New insights into progressive supranuclear palsy
    Albers, DS
    Augood, SJ
    [J]. TRENDS IN NEUROSCIENCES, 2001, 24 (06) : 347 - 352
  • [9] Decreased striatal dopaminergic innervation in REM sleep behavior disorder
    Albin, RL
    Koeppe, RA
    Chervin, RD
    Consens, FB
    Wernette, K
    Frey, KA
    Aldrich, MS
    [J]. NEUROLOGY, 2000, 55 (09) : 1410 - 1412
  • [10] Initial agonist treatment of Parkinson disease - A critique
    Albin, RL
    Frey, KA
    [J]. NEUROLOGY, 2003, 60 (03) : 390 - 394